|
- Elanco
At Elanco, we are united by a genuine love and care for animals Our purpose - making life better for animals, makes life better - fuels us to break boundaries and inspires us to push further, transforming animal care for healthier animals and a healthier, more sustainable world
- Elanco - Wikipedia
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested
- Elanco - 搜狗百科
Elanco成立于1954年，总部位于美国印第安纳州，是一家国际动物保健公司。 该公司为全球90多个国家的兽医和动物食品生产者提供产品，以帮助动物预防和治疗疾病。 Elanco的使命是改善动物健康状况，以推动地球和全人类健康发展。
- How Elanco Animal Health Is Outgrowing Rivals As Protein, Pet Health . . .
Elanco Animal Health CEO Jeff Simmons says the company is in the best position it's been in years Elanco stock has surged
- Products - @Elanco
Learn more about Elanco's farm animal and pet health products tailored to your specific needs
- Elanco Investor Day Defines New Era as Sustainable Growth Company
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and
- Elanco International Fact Sheet
Elanco Animal Health (NYSE: ELAN) is a global animal health company that develops products and knowledge services to prevent and treat disease in food animals and pets in more than 90 countries
- $1. 1 Billion Innovation Revenue Expected in 2026 as Elanco Restructures . . .
Elanco revealed a three-year financial outlook targeting low double-digit adjusted EPS growth starting 2026, driven by an expected $1 1 billion in innovation revenue and a path to reduce net leverage below 3x by 2027 The plan includes a $175 million restructuring charge to optimize its R D and manufacturing footprint, targeting $200 million to $250 million in adjusted EBITDA savings by 2030
|
|
|